Newer quinolones in the long term prophylaxis of recurrent urinary tract infections (UTI)

Drugs

Volumn 58, Issue SUPPL. 2, 1999, Pages 99-102

  Krcméry, Silvester ^a   Hromec, Juraj ^a   Tvrdikova, Miroslava ^a   Hassan, Mahmoud ^a   Gulla, Dussan ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; DRUG URINE LEVEL; ENTEROCOCCUS; ESCHERICHIA COLI; FECES MICROFLORA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INSOMNIA; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PREMENOPAUSE; RECURRENT INFECTION; STATISTICAL ANALYSIS; URINARY TRACT INFECTION;

4-QUINOLONES; ANIMALS; ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; HUMANS; RECURRENCE; URINARY TRACT INFECTIONS;

ENTEROCOCCUS; ESCHERICHIA COLI;

EID: 0344172166     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958003-00014     Document Type: Conference Paper

References (12)

1. Naber KG. Fluoroquinolones in urinary tract infections - proper and improper use. Drugs 1996; 52 Suppl. 2: 27-33
2. Guibert J, Humbert G, Delavault P. Antimicrobial prophylaxis for recurrent urinary tract infections with pefloxacin. In: Einhorn J, Nord CE, Norrby SR, editors. Recent Advances in Chemotherapy. Proceedings of the 18th International Congress of Chemotherapy; 1993 Jun 27-Jul 2: Stockholm. International Society of Chemotherapy, 1993: 743-4
3. Kunin CM. Chemoprophylaxis and suppressive therapy in the management of urinary tract infections. J Antimicrob Chemother 1994; 33: 51-62
4. Viitanen J, Talja M, Jusilla E. Randomized controlled study of chemoprophylaxis in transurethral prostatectomy. J Urol 1993; 150: 1715-7
5. Nicolle LE, Harding GKM, Ronald AR, et al. Prospective, randomized placebo controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women. Antimicrob Agents Chemother 1989; 33: 1032-5
6. Hofbauer H, Kinzig M, Naber KG, et al. Urine bactericidal titers of norfloxacin and pefloxacin in volunteers receiving a single oral dose of 800 mg [abstract]. Proceedings of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1994 Oct 4-7: Orlando, Florida. Washington DC: American Society for Microbiology, 1994: 20
7. Hooton TM. A simplified approach to urinary tract infection. Hosp Pract 1995; 14:23-30
8. Hooton TM, Scholes D, Stamm WE, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996; 335: 468-74
9. Krcmery S, Hromec J. Long-term chemoprophylaxis of recurrent urinary tract infections in women. In: Berkarda B, editor. Proceedings of the 10th Mediterranean Congress of Chemotherapy: 1996: Bologna; Mediterranean Society of Chemotherapy, Monduzzi Editore, 1996: 201-5
10. Pfau A, Sacks TG. Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women. J Urol 1994; 152: 136-41
11. Melekos MD, Asbach HW, Naber KG, et al. Long-term post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol 1997; 157: 865-78
12. Raz R, Stamm WE. A controlled trial of intravaginal oestradiol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 753-6